BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16709005)

  • 1. [Drug-induced renal calculi].
    Servais A; Daudon M; Knebelman B
    Ann Urol (Paris); 2006 Apr; 40(2):57-68. PubMed ID: 16709005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced renal calculi: epidemiology, prevention and management.
    Daudon M; Jungers P
    Drugs; 2004; 64(3):245-75. PubMed ID: 14871169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.
    Daudon M; Frochot V; Bazin D; Jungers P
    Drugs; 2018 Feb; 78(2):163-201. PubMed ID: 29264783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nephrolithiasis in a HIV infected patient treated with indinavir].
    Brzósko S; Hryszko T; Panasiuk B; Prokopowicz D; Myśliwiec M
    Przegl Lek; 2001; 58(6):528-9. PubMed ID: 11816748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prevalence and analysis of risk factors for indinavir nephrolithiasis.
    Saltel E; Angel JB; Futter NG; Walsh WG; O'Rourke K; Mahoney JE
    J Urol; 2000 Dec; 164(6):1895-7. PubMed ID: 11061951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-induced urinary calculi in 1999].
    Daudon M
    Prog Urol; 1999 Dec; 9(6):1023-33. PubMed ID: 10658246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic crystalluria associated with indinavir.
    Famularo G; Di Toro S; Moretti S; De Simone C
    Ann Pharmacother; 2000 Dec; 34(12):1414-8. PubMed ID: 11144699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Crystalluria and nephrolithiasis during therapy with the protease inhibitor indinavir].
    Rickerts V; Kober A; Stille W
    Dtsch Med Wochenschr; 1997 Jun; 122(24):803. PubMed ID: 9229567
    [No Abstract]   [Full Text] [Related]  

  • 9. Anuria and acute renal failure resulting from indinavir sulfate induced nephrolithiasis.
    Witte M; Tobon A; Gruenenfelder J; Goldfarb R; Coburn M
    J Urol; 1998 Feb; 159(2):498-9. PubMed ID: 9649271
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urinary lithiasis secondary to indinavir in an HIV-positive patient].
    Moyano Calvo JL; Huesa Martínez I; Cruz Navarro N; Leal Arenas J; León Dueñas E; Morales López A; Maestro Durán JL; Ramírez Mendoza A
    Arch Esp Urol; 2001 Dec; 54(10):1117-20. PubMed ID: 11852520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal lithiasis due to indinavir].
    Fernández JM; Robles JE; Regojo JM; López J; Sánchez D; Arocena J; Rosell D; Zudaire JJ; Berián JM
    Rev Med Univ Navarra; 2002; 46(3):28-32. PubMed ID: 12685114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease inhibitor-induced urolithiasis.
    Gentle DL; Stoller ML; Jarrett TW; Ward JF; Geib KS; Wood AF
    Urology; 1997 Oct; 50(4):508-11. PubMed ID: 9338723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indinavir-associated asymptomatic nephrolithiasis and renal cortex atrophy in two HIV-1 infected children.
    van Rossum AM; Dieleman JP; Fraaij PL; Cransberg K; Hartwig NG; Gyssens IC; de Groot R
    AIDS; 2001 Sep; 15(13):1745-7. PubMed ID: 11546957
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection.
    Malavaud B; Dinh B; Bonnet E; Izopet J; Payen JL; Marchou B
    Antivir Ther; 2000 Mar; 5(1):3-5. PubMed ID: 10846585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nephritic colic due to indinavir].
    Hermieu JF; Prévot MH; Ravery V; Moulinier F; Delmas V; Bouvet E; Boccon-Gibod L
    Presse Med; 1998 Mar; 27(10):465-7. PubMed ID: 9767973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of indinavir-associated renal complications in Thai HIV-infected patients.
    Avihingsanon A; Avihingsanon Y; Darnpornprasert P; Kerr S; Ungsedhapand C; Duncombe C; Ubolyam S; Ruxrungtham K; Phanuphak P
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S21-7. PubMed ID: 17044450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indinavir crystalluria: identification of patients at increased risk of developing nephrotoxicity.
    Trainor LD; Steinberg JP; Austin GW; Solomon HM
    Arch Pathol Lab Med; 1998 Mar; 122(3):256-9. PubMed ID: 9823864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urolithiasis associated with the protease inhibitor indinavir.
    Bruce RG; Munch LC; Hoven AD; Jerauld RS; Greenburg R; Porter WH; Rutter PW
    Urology; 1997 Oct; 50(4):513-8. PubMed ID: 9338724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of environmental temperature on incidence of indinavir-related nephrolithiasis.
    Martínez E; Leguizamón M; Mallolas J; Miró JM; Gatell JM
    Clin Infect Dis; 1999 Aug; 29(2):422-5. PubMed ID: 10476752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indinavir nephrolithiasis in warm climates.
    Bach MC; Godofsky EW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Mar; 14(3):296-7. PubMed ID: 9117466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.